MedWatch

William Demant invests in implant business: "One of the best opportunities for the company"

Danish hearing device group William Demant has made substantial investments to pick up pace with the implant division, Oticon Medical, after an unimpressing result in 2018. The company will only focus on profitable markets and getting access to the US, says the CEO.

Søren Nielsen, CEO in William Demant. | Foto: Ritzau Scanpix/Kenneth Lysbjerg Koustrup

Although sales of hearing devices generate the majority of William Demant's total revenue, most of the growth potential is located elsewhere - in the company's implant division, Oticon Medical, that includes implants and bone-anchored systems.

William Demant is still a small player in this market, but that also makes for more growth opportunities. In fact, the Danish hearing device group considers implants the most potential market for generating growth.

Læs hele artiklen

Få 14 dages fri adgang.
Det kræver intet kreditkort.

  • Adgang til alle låste artikler
  • Modtag vores daglige nyhedsbreve
  • Fuld adgang til vores app
Der skete en fejl. Prøv venligst igen senere

Få fuld adgang til dig og dine kollegaer.

Start et gratis virksomhedsprøveabonnement

Mere fra MedWatch

Relaterede

Seneste nyt

Ledige job

Se flere jobs

Se flere jobs

Latest news

Seneste nyt fra Watch Medier